Philip J. Barter

Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

John C. LaRosa, Scott M. Grundy, David D. Waters et al. · New England Journal of Medicine · 2005 · 3.5K citations · Full text

Medicine, Cardiology, Pharmacology +12

Effects of Torcetrapib in Patients at High Risk for Coronary Events

Philip J. Barter, Mark J. Caulfield, Mats Eriksson et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text

Medicine, Cardiology, Pharmacology +14

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

Josée Dupuis, Claudia Langenberg, Inga Prokopenko et al. · Nature Genetics · 2010 · 2.2K citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Gregory G. Schwartz, Anders Olsson, Markus Abt et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

Medicine, Cardiology, Pharmacology +17

HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events

Philip J. Barter, Antonio M. Gotto, John C. LaRosa et al. · New England Journal of Medicine · 2007 · 1.6K citations

Medicine, Cardiology, Clinical Epidemiology +9